Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China

PurposeCarbapenem-resistant Klebsiella pneumoniae (CRKP) producing carbapenemases poses a global threat to public health. Antimicrobial agent combinations have been promoted as a potential therapeutic strategy for infections. The most effective antimicrobial combinations against CRKP strains produci...

Full description

Saved in:
Bibliographic Details
Main Authors: Congcong Liu, Yuchen Wu, Yanyan Zhang, Zelin Yan, Danxia Gu, Hongwei Zhou, Ning Dong, Chang Cai, Gongxiang Chen, Rong Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2024.1519319/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591673643761664
author Congcong Liu
Congcong Liu
Yuchen Wu
Yanyan Zhang
Zelin Yan
Danxia Gu
Danxia Gu
Hongwei Zhou
Ning Dong
Chang Cai
Gongxiang Chen
Rong Zhang
author_facet Congcong Liu
Congcong Liu
Yuchen Wu
Yanyan Zhang
Zelin Yan
Danxia Gu
Danxia Gu
Hongwei Zhou
Ning Dong
Chang Cai
Gongxiang Chen
Rong Zhang
author_sort Congcong Liu
collection DOAJ
description PurposeCarbapenem-resistant Klebsiella pneumoniae (CRKP) producing carbapenemases poses a global threat to public health. Antimicrobial agent combinations have been promoted as a potential therapeutic strategy for infections. The most effective antimicrobial combinations against CRKP strains producing different carbapenemases are currently unclear, particularly those producing the KPC variant carbapenemases. This study is aimed to evaluate the effectiveness of various antimicrobial agent combinations against CRKP strains with different carbapenemases.MethodsA checkerboard assay involving 24 antimicrobial agent combinations was conducted on 44 strains of carbapenemase-producing CRKP isolated from patients of which 13 CRKP strains carried single KPC variants. The 24 antimicrobial combinations were based on meropenem, polymyxin, tigecycline, ceftazidime/avibactam, respectively. The fractional inhibitory concentration (FIC) indexes were calculated for each combination of antimicrobial agents.ResultsThe distribution of carbapenemases in 44 CRKP strains was as follows: KPC variants (n = 13, 29.5%), KPC-2 (n = 10, 22.7%), metallo-β-lactamases (n = 9, 20.5%), OXA-48-like (n = 12, 27.3%). In the checkerboard assay, the combination of polymyxin and aztreonam exhibited the highest synergistic effect against CRKP strains, with a rate of 95.5% (42/44). This was followed by polymyxin-meropenem at 88.6% (39/44) and polymyxin-levofloxacin at 68.2% (30/44). Additionally, polymyxin-aztreonam combination and polymyxin-meropenem showed the highest sum of synergistic and additive rates of 100.0% against KPC variant-producing CRKP strains. Notably, ceftazidime/avibactam-based combinations exhibited better synergistic effects on KPC variant-producing CRKP strains compared to other CRKP strains with adjusted p value <0.05.ConclusionOur study suggests that the combinations of antimicrobial agent could serve as potential treatment strategies against CRKP infections. Furthermore, the effectiveness of these combinations is influenced by the types of carbapenemases present. Ceftazidime/avibactam-based combinations have showed superior synergistic effects on KPC variant-producing CRKP strains.
format Article
id doaj-art-07f9d96f7e934d9cb91b0a4563308849
institution Kabale University
issn 1664-302X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj-art-07f9d96f7e934d9cb91b0a45633088492025-01-22T07:11:32ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2025-01-011510.3389/fmicb.2024.15193191519319Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in ChinaCongcong Liu0Congcong Liu1Yuchen Wu2Yanyan Zhang3Zelin Yan4Danxia Gu5Danxia Gu6Hongwei Zhou7Ning Dong8Chang Cai9Gongxiang Chen10Rong Zhang11Department of Clinical Laboratory, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaDepartment of Clinical Laboratory, Zhejiang Provincial People's Hospital, Hangzhou, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaMOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Key Laboratory of Pathogen Bioscience and Anti-infective Medicine, School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, ChinaCollege of Animal Science and Technology, College of Veterinary Medicine, Zhejiang Agricultural and Forestry University, Hangzhou, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaPurposeCarbapenem-resistant Klebsiella pneumoniae (CRKP) producing carbapenemases poses a global threat to public health. Antimicrobial agent combinations have been promoted as a potential therapeutic strategy for infections. The most effective antimicrobial combinations against CRKP strains producing different carbapenemases are currently unclear, particularly those producing the KPC variant carbapenemases. This study is aimed to evaluate the effectiveness of various antimicrobial agent combinations against CRKP strains with different carbapenemases.MethodsA checkerboard assay involving 24 antimicrobial agent combinations was conducted on 44 strains of carbapenemase-producing CRKP isolated from patients of which 13 CRKP strains carried single KPC variants. The 24 antimicrobial combinations were based on meropenem, polymyxin, tigecycline, ceftazidime/avibactam, respectively. The fractional inhibitory concentration (FIC) indexes were calculated for each combination of antimicrobial agents.ResultsThe distribution of carbapenemases in 44 CRKP strains was as follows: KPC variants (n = 13, 29.5%), KPC-2 (n = 10, 22.7%), metallo-β-lactamases (n = 9, 20.5%), OXA-48-like (n = 12, 27.3%). In the checkerboard assay, the combination of polymyxin and aztreonam exhibited the highest synergistic effect against CRKP strains, with a rate of 95.5% (42/44). This was followed by polymyxin-meropenem at 88.6% (39/44) and polymyxin-levofloxacin at 68.2% (30/44). Additionally, polymyxin-aztreonam combination and polymyxin-meropenem showed the highest sum of synergistic and additive rates of 100.0% against KPC variant-producing CRKP strains. Notably, ceftazidime/avibactam-based combinations exhibited better synergistic effects on KPC variant-producing CRKP strains compared to other CRKP strains with adjusted p value <0.05.ConclusionOur study suggests that the combinations of antimicrobial agent could serve as potential treatment strategies against CRKP infections. Furthermore, the effectiveness of these combinations is influenced by the types of carbapenemases present. Ceftazidime/avibactam-based combinations have showed superior synergistic effects on KPC variant-producing CRKP strains.https://www.frontiersin.org/articles/10.3389/fmicb.2024.1519319/fullcarbapenem-resistant Klebsiella pneumoniaecheckerboard assayantimicrobial agent combinationsKPC variantceftazidime/avibactam-based dual combinations
spellingShingle Congcong Liu
Congcong Liu
Yuchen Wu
Yanyan Zhang
Zelin Yan
Danxia Gu
Danxia Gu
Hongwei Zhou
Ning Dong
Chang Cai
Gongxiang Chen
Rong Zhang
Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China
Frontiers in Microbiology
carbapenem-resistant Klebsiella pneumoniae
checkerboard assay
antimicrobial agent combinations
KPC variant
ceftazidime/avibactam-based dual combinations
title Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China
title_full Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China
title_fullStr Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China
title_full_unstemmed Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China
title_short Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China
title_sort effectiveness of antimicrobial agent combinations against carbapenem producing klebsiella pneumoniae with kpc variants in china
topic carbapenem-resistant Klebsiella pneumoniae
checkerboard assay
antimicrobial agent combinations
KPC variant
ceftazidime/avibactam-based dual combinations
url https://www.frontiersin.org/articles/10.3389/fmicb.2024.1519319/full
work_keys_str_mv AT congcongliu effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina
AT congcongliu effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina
AT yuchenwu effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina
AT yanyanzhang effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina
AT zelinyan effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina
AT danxiagu effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina
AT danxiagu effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina
AT hongweizhou effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina
AT ningdong effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina
AT changcai effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina
AT gongxiangchen effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina
AT rongzhang effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina